Wei, S., Duffy, C., & Allison, J. (2018). Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discovery. https://doi.org/10.1158/2159-8290.CD-18-0367 (Original work published 2018)

Sharma, A., Subudhi, S., Blando, J., Scutti, J., Vence, L., Wargo, J., … Sharma, P. (2018). Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-18-0762 (Original work published 2018)

Goswami, S., Apostolou, I., Zhang, J., Skepner, J., Anandhan, S., Zhang, X., … Sharma, P. (2018). Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI99760 (Original work published 2018)

Ariyan, C., Brady, M., Siegelbaum, R., Hu, J., Bello, D., Rand, J., … Allison, J. (2018). Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. Cancer Immunology Research, 6(2), 189-200. https://doi.org/10.1158/2326-6066.CIR-17-0356

Khouri, I., Curbelo, F., Turturro, F., Jabbour, E., Milton, D., RL, B. , Jr, … Sharma, P. (2018). Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 24(5), 1011-1018. https://doi.org/10.1158/1078-0432.CCR-17-2777 (Original work published 2018)

, Spencer, C., Nezi, L., Reuben, A., Andrews, M., Karpinets, T., … Wargo, J. (2018). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (New York, N.Y.), 359(6371), 97-103. https://doi.org/10.1126/science.aan4236 (Original work published 2018)

Mbofung, R., McKenzie, J., Malu, S., Zhang, M., Peng, W., Liu, C., … Hwu, P. (2017). HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nature Communications, 8(1), 451. https://doi.org/10.1038/s41467-017-00449-z (Original work published 2017)

Reuben, A., Spencer, C., Prieto, P., , Reddy, S., Miller, J., … Wargo, J. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genomic Medicine, 2. https://doi.org/10.1038/s41525-017-0013-8 (Original work published 2017)

Wei, S., Levine, J., Cogdill, A., Zhao, Y., Anang, N., Andrews, M., … Allison, J. (2017). Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Cell, 170(6), 1120-1133.e17. https://doi.org/10.1016/j.cell.2017.07.024 (Original work published 2017)

Reuben, A., Gittelman, R., Gao, J., Zhang, J., Yusko, E., Wu, C., … Zhang, J. (2017). TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. Cancer Discovery, 7(10), 1088-1097. https://doi.org/10.1158/2159-8290.CD-17-0256